Table 4.

Distribution of patients based on pre-chemotherapy staging (T stage).

Study	T2 n (%)	T3 n (%)	T4 n (%)
Kim et al. [12]	–	–	–
van de Putte et al. [13]	11 (21.5)	25 (49)	15 (29.4)
Galsky et al. [14]	90 (62)	40 (27)	16 (11)
Gandhi et al. [15]	97 (65)	38 (25)	15 (10)
Chau et al. [16]	43 (51.8)	33 (39.8)	7 (8.4)
Khaled et al. [17]	1 (2)	45 (76)	13 (22)
Fairey et al. [18]	28 (49)	18 (31)	12 (20)
Pal et al. [19]	19 (91.7)	2 (8.3)	0 (0)
Matsubara et al. [20]	9 (36)	16 (64)
Scosyrev et al. [21]	6 (24)	19 (76)
Kaneko et al. [22]	15 (68.2)	6 (27.3)	1 (4.5)
Dash et al. [7]	19 (45)	19 (45)	4 (10)
Herchenhorn et al. [23]	11 (52.4)	2 (9.5)	8 (38.1)

–, not available.